Utilisation of Pentamidine as an Alternative for Pcp Prophylaxy in Hemato -Oncology Patients
published by Damascus University
in 2011
in Medicine
and research's language is
العربية
Download
Abstract in English
TMP-SMX is the first choice drug to prevent Pneumocystis jiroveci pneumonia
(PCP) in hemato-oncology patients. The utilization of alternative drugs (Pentamidine – Dapsone) was
suggested in some protocols in hemato-oncology. It seems that there is an increase in the utilization of
alternative drugs. The aim of the study was to evaluate the utilization of different drugs to prevent PCP
and to identify the reasons which lead to the utilization of alternative drugs.
References used
Shankar MS and Nania JJ . Management of Pneumocystis jirovici Pneumonia in Children Receiving Chemotherapy. Pediatr. Drugs 2007:9 (5):301-309
Carinii A. Formas de eschizogonia do Trypanozoma lewisi. Commun Soc Med Sao Palo 1910: 16:204
Kovacs JA, Gill VJ, Messnick S, et al. New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia. JAMA 2001: 286: 2450-60